Fitbit in healthcare partnership to take on Apple Watch

(Reuters) – Fitbit Inc (N:) is developing a method to detect irregular heart rhythm in time through a partnership with Bristol-Myers Squibb-Pfizer Alliance, as the wearable device maker looks to match a feature available on rival Apple Inc’s (O:) Watch.

Fitbit has been pushing deeper into the healthcare space and in August tied up with the Singapore government to provide fitness trackers and services in a health program that the company said could reach up to one million users. (https://reut.rs/2TWAkpG)

Under Thursday’s deal, the company’s devices will carry software that will help detect atrial fibrillation – the most common type of irregular heartbeat – after approval from the U.S. Food and Drug Administration.

Atrial fibrillation is a condition associated with irregular heart rhythm that increases the risk of stroke and is usually prevalent among people above 65 years of age.

About 2.7 million to 6 million people suffer from the condition in the United States, according to the Center of Disease Control and Prevention.

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.